Guardian Pharmacy Services, Inc.

GRDN Healthcare Medical Care Facilities

Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.

Revenue
−1.68%
EPS
+133.3%
Free cash flow
+88.9%

Quarter to September 2026, against a year earlier

39.72 2.37 −5.63%
Market cap
$2.5B
P/E
37.8×
Fwd P/E
33.3×
Dividend yield
—
F-score
7/9
Altman Z
10.28
Beneish M
−2.95
Dividend safety
n/a

Guardian Pharmacy Services, Inc. (GRDN) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Guardian Pharmacy Services, Inc. (GRDN) trades at a P/S ratio of 1.7×. Over the past ten years it has ranged from 0.0× (September 2024) to 2.1× (September 2026); the current reading is higher than 86% of that period. That is above the Medical Care Facilities industry median of 1.0× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 1.3× 26.70%
FY2024 1.0× —
FY2023 0.0× —

Quarterly newest first

Period P/S ratio Change
Sep 2026 1.8× (2.18%)
Jun 2026 1.8× 10.62%
Mar 2026 1.6× 26.40%
Dec 2025 1.3× 10.51%
8 more quarters

Against its own ten years

Low 0.0× High 2.1×
Ten-year median 1.3×
Current reading's percentile 86

P/S ratio against peers

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on GRDN